US Patent Issued to University of Iowa Research Foundation on May 12 for "JNK inhibitors as anticancer agents" (Iowa, California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,015, issued on May 12, was assigned to University of Iowa Research Foundation (Iowa City, Iowa).

"JNK inhibitors as anticancer agents" was invented by Aliasger K. Salem (Coralville, Iowa) and Somaya Ali Mohammed Elsaid Abdelrahman (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds that inhibit JNK, e.g., JNK2 and/or JNK3, such as fused thiophenes, and methods of making and using the compounds are provided."

The patent was filed on June 24, 2020, under Application No. 17/622,210.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p...